Osiris Therapeutics , a pioneer in developing drugs from stem cell, has sold off its culture-expanded mesenchymal stem cell business, including Prochymal, in October.
http://seekingalpha.com/article/1872151-osiris-focuses-on-biosurgery-after-selling-prochymal-stock-attractively-valued?source=feed
http://seekingalpha.com/article/1872151-osiris-focuses-on-biosurgery-after-selling-prochymal-stock-attractively-valued?source=feed
No comments:
Post a Comment